Assessing claims about the cost of new drug development: a critique of the public citizen and TB Alliance reports (original) (raw)
Related papers
The Price of Innovation: New Estimates of Drug Development Costs
Journal of Health Economics, 2003
The cost of drug development: A systematic review
Health Policy, 2011
Innovation in the pharmaceutical industry: New estimates of R&D costs
Journal of Health Economics, 2016
Health economics and outcomes research within drug development
Stefan Holmstrom, Ingela Wiklund
Drug Discovery Today, 2012
The $800 Million Pill: The Truth Behind the Cost of New Drugs
BMJ, 2004
Demythologizing the high costs of pharmaceutical research
BioSocieties, 2011
Demythologizing the high costs of pharmaceutical research Biosocieties 2011
Active Ingredients: Exploring the Key Factors Affecting the Rising Cost of Developing New Drugs*
INTERNATIONAL JOURNAL OF HEALTH SCIENCES (IJHS)
Measuring the Pace of New Drug Development in the User Fee ERA
Drug Information Journal, 2000
Returns on Research and Development for 1990s New Drug Introductions
PharmacoEconomics, 2002
Cost of innovation in the pharmaceutical industry
Journal of Health Economics, 1991
At a glance: economic impact of industry-sponsored clinical trials of pharmaceutical products
Journal of Medical Economics
Drug Development and the Cost of Capital
Optimization of Pharmaceutical R&D Programs and Portfolios, 2014
Pharmaceutical research and development: what do we get for all that money
The Cost of Pharmaceutical R&D: Is Biotech Different?
2007
The cost of biopharmaceutical R&D: is biotech different?
Managerial and Decision Economics, 2007
Molecular oncology, 2014
Commentary to "Patients not patents: drug research and development as a public enterprise
European journal of clinical investigation, 2017
The Economics of Drug Discovery and the Ultimate Valuation of Pharmacotherapies in the Marketplace
Josephine Sollano, M. Chambers
Clinical Pharmacology & Therapeutics, 2008
Revista Terceiro Incluído, 2024
The cost of pharmaceutical innovation to patients
Expert opinion on drug discovery, 2007
Cost of Biotech Drug Development and Affordability Issues in LMICs
Archives in Biomedical Engineering & Biotechnology
The Determinants of Pharmaceutical Research and Development Investments
Contributions in Economic Analysis & Policy, 2006
Value in Health, 2005
The Research-Based Pharmaceutical Industry and Society: What Is at Stake in the Future?
2014
The role of health technology assessment bodies in shaping drug development
Drug Design, Development and Therapy, 2014
Economics of New Oncology Drug Development
Journal of Clinical Oncology, 2007
A dynamic perspective on pharmaceutical competition, drug development and cost effectiveness
Health Policy, 2011
NICE and new : appraising innovation Innovation is essential in drug development but is not cheap
2010
Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009
Clinical pharmacology and therapeutics, 2011
Common Errors and Controversies in Pharmacoeconomic Analyses
PharmacoEconomics, 1998
Future challenges for health economics and health technology assessment of biological drugs
The European Journal of Health Economics, 2010
SCOPE OF PHARMACOECONOMICS To Pharmaceutical manufacturers
2015
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 2000
Chinese clinical oncology, 2014